| scholarly article | Q13442814 |
| P2093 | author name string | Kumar Sharma | |
| Joseph Satriano | |||
| P2860 | cites work | Obesity and Risk for Chronic Renal Failure | Q22241459 |
| The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 | Q24300456 | ||
| Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice | Q24303752 | ||
| A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy | Q24316492 | ||
| Adiponectin regulates albuminuria and podocyte function in mice | Q24324384 | ||
| LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing | Q24597817 | ||
| Upregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes | Q24656627 | ||
| Mechanisms of mitophagy | Q27310261 | ||
| Autophagy fights disease through cellular self-digestion | Q27860902 | ||
| Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains | Q28114920 | ||
| Prevalence of overweight and obesity in the United States, 1999-2004 | Q28305811 | ||
| The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism | Q28512608 | ||
| Suppression of chaperone-mediated autophagy in the renal cortex during acute diabetes mellitus | Q28564315 | ||
| Autophagy regulates lipid metabolism | Q29547421 | ||
| Autophagy is activated for cell survival after endoplasmic reticulum stress | Q29614485 | ||
| Termination of autophagy and reformation of lysosomes regulated by mTOR | Q29619817 | ||
| Role of mTOR in podocyte function and diabetic nephropathy in humans and mice | Q30500731 | ||
| Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. | Q33896647 | ||
| Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes | Q33959129 | ||
| Altered lipid content inhibits autophagic vesicular fusion | Q34017069 | ||
| Chaperone-mediated autophagy in protein quality control | Q34150995 | ||
| AMPKalpha1 regulates the antioxidant status of vascular endothelial cells | Q47801068 | ||
| Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. | Q51057544 | ||
| AMP-activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation. | Q53500309 | ||
| ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. | Q53616050 | ||
| The epidemiology of obesity | Q57196005 | ||
| Functional and structural changes in the kidney in the early stages of obesity | Q73928010 | ||
| Prevention of obesity-linked renal disease: age-dependent effects of dietary food restriction | Q74351905 | ||
| Rapamycin prevents early steps of the development of diabetic nephropathy in rats | Q80726615 | ||
| Altered autophagy in human adipose tissues in obesity | Q82295529 | ||
| Autophagy: a protective mechanism against nephrotoxicant-induced renal injury | Q83016434 | ||
| Obesity and chronic kidney disease | Q84219086 | ||
| Microautophagy: lesser-known self-eating | Q34232209 | ||
| Autophagy: basic principles and relevance to disease | Q34585381 | ||
| Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IkappaB kinase beta (IKKbeta)/NF-kappaB pathway | Q35213340 | ||
| Fatty acids suppress autophagic turnover in β-cells | Q35604849 | ||
| Pexophagy: the selective degradation of peroxisomes | Q35872257 | ||
| Emerging role of autophagy in kidney function, diseases and aging | Q36194753 | ||
| Sirtuins and renal diseases: relationship with aging and diabetic nephropathy | Q36304756 | ||
| Kidney growth during catabolic illness: what it does not destroy makes it grow stronger. | Q36803027 | ||
| Association between obesity and kidney disease: a systematic review and meta-analysis | Q36967756 | ||
| Recycle or die: the role of autophagy in cardioprotection. | Q37114188 | ||
| Risk factors for end-stage renal disease: 25-year follow-up | Q37307169 | ||
| Autophagy genes and ageing | Q37349831 | ||
| Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis | Q37446431 | ||
| Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. | Q37640916 | ||
| Autophagy: an adaptable modifier of tumourigenesis | Q37676660 | ||
| Autophagy and adipogenesis: implications in obesity and type II diabetes | Q37683310 | ||
| Regulation of autophagy by ROS: physiology and pathology | Q37781565 | ||
| Bnip3 as a dual regulator of mitochondrial turnover and cell death in the myocardium | Q37826367 | ||
| Implications of autophagy for glomerular aging and disease | Q37834371 | ||
| Autophagy as a therapeutic target in diabetic nephropathy | Q37949588 | ||
| Autophagy: a novel therapeutic target for kidney diseases | Q38042825 | ||
| Autophagy deficiency in beta cells leads to compromised unfolded protein response and progression from obesity to diabetes in mice | Q38330390 | ||
| p62 is a key regulator of nutrient sensing in the mTORC1 pathway. | Q38666713 | ||
| Spatial coupling of mTOR and autophagy augments secretory phenotypes. | Q39554934 | ||
| Sirolimus and proteinuria in renal transplant patients: evidence for a dose-dependent effect on slit diaphragm-associated proteins. | Q39583588 | ||
| Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice | Q39812158 | ||
| Endoplasmic reticulum stress induces autophagy in renal proximal tubular cells | Q39849425 | ||
| Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. | Q39878605 | ||
| Inhibition of MTOR disrupts autophagic flux in podocytes | Q41812610 | ||
| mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice | Q41912848 | ||
| Autophagy: roles in obesity-induced ER stress and adiponectin downregulation in adipocytes | Q42009315 | ||
| Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. | Q42491649 | ||
| Autophagy in aging, disease and death: the true identity of a cell death impostor | Q42609173 | ||
| Autophagy-mediated insulin receptor down-regulation contributes to endoplasmic reticulum stress-induced insulin resistance | Q42797937 | ||
| Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1. | Q42807283 | ||
| Cholesterol depletion induces autophagy | Q42834297 | ||
| Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? | Q43293883 | ||
| Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells | Q44468960 | ||
| The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. | Q46021736 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| autophagy | Q288322 | ||
| P304 | page(s) | iv29-36 | |
| P577 | publication date | 2013-07-30 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Autophagy and metabolic changes in obesity-related chronic kidney disease | |
| P478 | volume | 28 Suppl 4 |
| Q54951434 | Advanced oxidation protein products inhibit the autophagy of renal tubular epithelial cells. |
| Q46312225 | Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential |
| Q55069288 | Beneficial Effects of AMP-Activated Protein Kinase Agonists in Kidney Ischemia-Reperfusion: Autophagy and Cellular Stress Markers. |
| Q47144150 | High Endogenous Accumulation of ω-3 Polyunsaturated Fatty Acids Protect against Ischemia-Reperfusion Renal Injury through AMPK-Mediated Autophagy in Fat-1 Mice |
| Q42945769 | Hydrogen sulfide mitigates hyperglycemic remodeling via liver kinase B1-adenosine monophosphate-activated protein kinase signaling. |
| Q38266793 | Mechanisms and biological functions of autophagy in diseased and ageing kidneys. |
| Q24296638 | NRBF2 regulates macroautophagy as a component of Vps34 Complex I |
| Q42371719 | Obesity-induced kidney injury is attenuated by amelioration of aberrant PHD2 activation in proximal tubules |
| Q92812275 | PPARα-Dependent Modulation by Metformin of the Expression of OCT-2 and MATE-1 in the Kidney of Mice |
| Q26765293 | Role of autophagy in chronic kidney diseases |
| Q47831395 | Targeting Cellular Stress Mechanisms and Metabolic Homeostasis by Chinese Herbal Drugs for Neuroprotection. |
| Q28269939 | Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES |
Search more.